Page last updated: 2024-10-17

n(g),n(g')-dimethyl-l-arginine and Alloxan Diabetes

n(g),n(g')-dimethyl-l-arginine has been researched along with Alloxan Diabetes in 25 studies

N,N-dimethylarginine: asymmetric dimethylarginine; do not confuse with N,N'-dimethylarginine

Research Excerpts

ExcerptRelevanceReference
"Endothelial dysfunction, characterized by reduced bioavailability of nitric oxide and increased oxidative stress, is a hallmark characteristic in diabetes and diabetic nephropathy (DN)."1.56Enhancing kidney DDAH-1 expression by adenovirus delivery reduces ADMA and ameliorates diabetic nephropathy. ( Awad, AS; Cooper, TK; Gao, T; Morris, SM; Stanley, K; Wetzel, MD, 2020)
"Diabetes and its complications, such as diabetic nephropathy, dramatically increase cardiovascular risk."1.46ADMA reduction does not protect mice with streptozotocin-induced diabetes mellitus from development of diabetic nephropathy. ( Bode-Böger, SM; Brilloff, S; Heinrich, A; Hohenstein, B; Hugo, CPM; Jarzebska, N; Martens-Lobenhoffer, J; Rodionov, RN; Todorov, VT; Weiss, N, 2017)

Research

Studies (25)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (4.00)18.2507
2000's7 (28.00)29.6817
2010's13 (52.00)24.3611
2020's4 (16.00)2.80

Authors

AuthorsStudies
Huang, CY1
Zhou, T2
Li, G1
Li, MY1
Xiong, XM1
Wu, MT1
Jiang, JL2
Rodionov, RN2
Jarzebska, N2
Schneider, A1
Rexin, A1
Sradnick, J1
Brilloff, S2
Martens-Lobenhoffer, J2
Bode-Böger, SM2
Todorov, V1
Hugo, C1
Weiss, N2
Hohenstein, B2
Leffler, KE1
Abdel-Rahman, AA1
Wetzel, MD1
Gao, T1
Stanley, K1
Cooper, TK1
Morris, SM1
Awad, AS1
Hussein, J1
El-Naggar, M2
Badawy, E1
El-Laithy, N1
El-Waseef, M1
Hassan, H1
Abdel-Latif, Y1
Xiong, Y6
He, YL1
Li, XM1
Nie, F1
Zhou, XK1
Shi, L1
Zhao, C1
Wang, H1
Lei, T1
Liu, S1
Cao, J1
Lu, Z1
Heinrich, A1
Todorov, VT1
Hugo, CPM1
Du, MR1
Yan, L1
Li, NS1
Wang, YJ1
Hu, LL1
Zhang, KQ1
Tian, T1
Zhang, H1
Fu, Q1
Hussein, JS1
Rasheed, W1
Ramzy, T1
Nabeeh, M1
Harvy, M1
El-Toukhy, S1
Ali, O1
Raafat, J1
Cheng, SL1
Ramachandran, B1
Behrmann, A1
Shao, JS1
Mead, M1
Smith, C1
Krchma, K1
Bello Arredondo, Y1
Kovacs, A1
Kapoor, K1
Brill, LM1
Perera, R1
Williams, BO1
Towler, DA1
Chen, Y1
Xu, X1
Sheng, M1
Zhang, X1
Gu, Q1
Zheng, Z1
Lu, CW1
Guo, Z1
Feng, M1
Wu, ZZ1
He, ZM1
Soro-Paavonen, A1
Zhang, WZ1
Venardos, K1
Coughlan, MT1
Harris, E1
Tong, DC1
Brasacchio, D1
Paavonen, K1
Chin-Dusting, J1
Cooper, ME1
Kaye, D1
Thomas, MC1
Forbes, JM1
Chen, N1
Leng, YP1
Xu, WJ1
Luo, JD1
Chen, MS1
Salum, E1
Kampus, P1
Zilmer, M1
Eha, J1
Butlin, M1
Avolio, AP1
Põdramägi, T1
Arend, A1
Aunapuu, M1
Kals, J1
Ojima, A1
Ishibashi, Y1
Matsui, T1
Maeda, S1
Nishino, Y1
Takeuchi, M1
Fukami, K1
Yamagishi, S1
Lin, KY1
Ito, A1
Asagami, T1
Tsao, PS1
Adimoolam, S1
Kimoto, M1
Tsuji, H1
Reaven, GM1
Cooke, JP1
Fu, YF1
Fu, SH1
Zhou, HH1
Lei, M1
Fu, S1
Fu, Y1
Palm, F1
Buerk, DG1
Carlsson, PO1
Hansell, P1
Liss, P1
Yang, ZC1
Xia, K1
Wang, L1
Jia, SJ1
Li, D1
Zhang, Z1
Deng, S1
Zhang, XH1
Deng, HW2
Li, YJ2
Chobanyan, K1
Thum, T1
Suchy, MT1
Zhu, B1
Mitschke, A1
Gutzki, FM1
Beckmann, B1
Stichtenoth, DO1
Tsikas, D1
Lu, R1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
The Effect of Dexamethasone Implant on Retinal Nerve Fiber and Optic Disc Morphology in Patients With Diabetic Maculopathy[NCT03927118]43 participants (Actual)Observational2018-02-01Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

25 other studies available for n(g),n(g')-dimethyl-l-arginine and Alloxan Diabetes

ArticleYear
Asymmetric dimethylarginine aggravates blood-retinal barrier breakdown of diabetic retinopathy via inhibition of intercellular communication in retinal pericytes.
    Amino acids, 2019, Volume: 51, Issue:10-12

    Topics: Animals; Apoptosis; Arginine; Blood-Retinal Barrier; Cell Communication; Cell Membrane Permeability;

2019
ADMA elevation does not exacerbate development of diabetic nephropathy in mice with streptozotocin-induced diabetes mellitus.
    Atherosclerosis. Supplements, 2019, Volume: 40

    Topics: Amidohydrolases; Animals; Arginine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glomeru

2019
Restoration of Adiponectin-Connexin43 Signaling Mitigates Myocardial Inflammation and Dysfunction in Diabetic Female Rats.
    Journal of cardiovascular pharmacology, 2020, Volume: 75, Issue:3

    Topics: Adiponectin; Animals; Arginine; Connexin 43; Diabetes Mellitus, Experimental; Diabetes Mellitus, Typ

2020
Enhancing kidney DDAH-1 expression by adenovirus delivery reduces ADMA and ameliorates diabetic nephropathy.
    American journal of physiology. Renal physiology, 2020, 02-01, Volume: 318, Issue:2

    Topics: Adenoviridae; Albuminuria; Amidohydrolases; Animals; Arginine; Cytokines; Diabetes Mellitus, Experim

2020
Homocysteine and Asymmetrical Dimethylarginine in Diabetic Rats Treated with Docosahexaenoic Acid-Loaded Zinc Oxide Nanoparticles.
    Applied biochemistry and biotechnology, 2020, Volume: 191, Issue:3

    Topics: Animals; Arginine; Cellulose; Diabetes Mellitus, Experimental; Docosahexaenoic Acids; Homocysteine;

2020
Endogenous asymmetric dimethylarginine accumulation precipitates the cardiac and mitochondrial dysfunctions in type 1 diabetic rats.
    European journal of pharmacology, 2021, Jul-05, Volume: 902

    Topics: Acetylcysteine; Animals; Arginine; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus

2021
Dimethylarginine Dimethylaminohydrolase 1 Deficiency Induces the Epithelial to Mesenchymal Transition in Renal Proximal Tubular Epithelial Cells and Exacerbates Kidney Damage in Aged and Diabetic Mice.
    Antioxidants & redox signaling, 2017, Dec-01, Volume: 27, Issue:16

    Topics: Aging; Aldosterone; Amidohydrolases; Animals; Arginine; Cell Line; Creatinine; Diabetes Mellitus, Ex

2017
ADMA reduction does not protect mice with streptozotocin-induced diabetes mellitus from development of diabetic nephropathy.
    Atherosclerosis. Supplements, 2017, Volume: 30

    Topics: Albuminuria; Amidohydrolases; Animals; Arginine; Cell Proliferation; Creatinine; Diabetes Mellitus,

2017
Asymmetric dimethylarginine contributes to retinal neovascularization of diabetic retinopathy through EphrinB2 pathway.
    Vascular pharmacology, 2018, Volume: 108

    Topics: Amidohydrolases; Animals; Arginine; Cell Hypoxia; Cell Line; Diabetes Mellitus, Experimental; Diabet

2018
Probucol improves erectile function via Activation of Nrf2 and coordinates the HO-1 / DDAH / PPAR-γ/ eNOS pathways in streptozotocin-induced diabetic rats.
    Biochemical and biophysical research communications, 2018, 12-09, Volume: 507, Issue:1-4

    Topics: Amidohydrolases; Animals; Arginine; Blood Glucose; Body Weight; Cyclic GMP; Diabetes Mellitus, Exper

2018
Synthesis of docosahexaenoic acid-loaded silver nanoparticles for improving endothelial dysfunctions in experimental diabetes.
    Human & experimental toxicology, 2019, Volume: 38, Issue:8

    Topics: Animals; Arginine; Aryldialkylphosphatase; Blood Glucose; Diabetes Mellitus, Experimental; DNA Damag

2019
Vascular smooth muscle LRP6 limits arteriosclerotic calcification in diabetic LDLR-/- mice by restraining noncanonical Wnt signals.
    Circulation research, 2015, Jul-03, Volume: 117, Issue:2

    Topics: Animals; Arginine; Arteriosclerosis; Calcinosis; Diabetes Mellitus, Experimental; Dietary Fats; Friz

2015
PRMT-1 and DDAHs-induced ADMA upregulation is involved in ROS- and RAS-mediated diabetic retinopathy.
    Experimental eye research, 2009, Volume: 89, Issue:6

    Topics: Amidohydrolases; Animals; Arginine; Blotting, Western; Cells, Cultured; Cyclic GMP; Diabetes Mellitu

2009
Ex vivo gene transferring of human dimethylarginine dimethylaminohydrolase-2 improved endothelial dysfunction in diabetic rat aortas and high glucose-treated endothelial cells.
    Atherosclerosis, 2010, Volume: 209, Issue:1

    Topics: Amidohydrolases; Animals; Aorta; Arginine; Diabetes Mellitus; Diabetes Mellitus, Experimental; Endot

2010
Advanced glycation end-products induce vascular dysfunction via resistance to nitric oxide and suppression of endothelial nitric oxide synthase.
    Journal of hypertension, 2010, Volume: 28, Issue:4

    Topics: Animals; Aorta, Thoracic; Arginine; Cattle; Cells, Cultured; Diabetes Mellitus; Diabetes Mellitus, E

2010
Contribution of endogenous inhibitor of nitric oxide synthase to hepatic mitochondrial dysfunction in streptozotocin-induced diabetic rats.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2011, Volume: 27, Issue:3-4

    Topics: Adenosine Triphosphate; Animals; Arginine; Cell Line, Tumor; Diabetes Mellitus, Experimental; Enzyme

2011
Effect of vitamin D on aortic remodeling in streptozotocin-induced diabetes.
    Cardiovascular diabetology, 2012, Jul-13, Volume: 11

    Topics: Animals; Aorta, Thoracic; Aortic Diseases; Arginine; Biomarkers; Blood Pressure; Cholecalciferol; Di

2012
Glucagon-like peptide-1 receptor agonist inhibits asymmetric dimethylarginine generation in the kidney of streptozotocin-induced diabetic rats by blocking advanced glycation end product-induced protein arginine methyltranferase-1 expression.
    The American journal of pathology, 2013, Volume: 182, Issue:1

    Topics: Animals; Arginine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drug Evaluation, Preclin

2013
Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase.
    Circulation, 2002, Aug-20, Volume: 106, Issue:8

    Topics: Amidohydrolases; Animals; Antioxidants; Aorta; Arginine; Cell Line; Cells, Cultured; Cyclic GMP; Dia

2002
Elevated levels of the serum endogenous inhibitor of nitric oxide synthase and metabolic control in rats with streptozotocin-induced diabetes.
    Journal of cardiovascular pharmacology, 2003, Volume: 42, Issue:2

    Topics: Animals; Arginine; Blood Glucose; Chromatography, High Pressure Liquid; Diabetes Mellitus, Experimen

2003
Effect of diabetic duration on serum concentrations of endogenous inhibitor of nitric oxide synthase in patients and rats with diabetes.
    Life sciences, 2005, May-27, Volume: 77, Issue:2

    Topics: Adult; Aged; Animals; Arginine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Female;

2005
Reduced nitric oxide concentration in the renal cortex of streptozotocin-induced diabetic rats: effects on renal oxygenation and microcirculation.
    Diabetes, 2005, Volume: 54, Issue:11

    Topics: Animals; Arginine; Diabetes Mellitus, Experimental; Kidney Cortex; Male; Microcirculation; NG-Nitroa

2005
Asymmetric dimethylarginine reduced erythrocyte deformability in streptozotocin-induced diabetic rats.
    Microvascular research, 2007, Volume: 73, Issue:2

    Topics: Animals; Aorta, Thoracic; Arginine; Diabetes Mellitus, Experimental; Endothelium, Vascular; Erythroc

2007
GC-MS assay for hepatic DDAH activity in diabetic and non-diabetic rats by measuring dimethylamine (DMA) formed from asymmetric dimethylarginine (ADMA): evaluation of the importance of S-nitrosothiols as inhibitors of DDAH activity in vitro and in vivo in
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2007, Oct-15, Volume: 858, Issue:1-2

    Topics: Amidohydrolases; Animals; Arginine; Catalysis; Diabetes Mellitus, Experimental; Dimethylamines; Enzy

2007
Elevation of an endogenous inhibitor of nitric oxide synthase in diabetic rat serum.
    Zhongguo yao li xue bao = Acta pharmacologica Sinica, 1997, Volume: 18, Issue:6

    Topics: Animals; Aorta; Arginine; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Male; Nitric Oxide Syn

1997